Emerald Development Managers

Type

Venture Capital

Status

Active

Location

New York, United States

Total investments

36

Average round size

16M

Portfolio companies

24

Rounds per year

1.20

Lead investments

3

Follow on index

0.33

Exits

1

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareRoboticsCyber SecuritySecurityMedicalCloud Security

Summary

The main department of described VC is located in the New York. The venture was found in North America in United States.

Besides them, we counted 1 critical employee of this fund in our database.

When the investment is from Emerald Development Managers the average startup value is 10-50 millions dollars. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular fund investment industries, there are Health Care, Biotechnology. The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight DriverUp, Cyware Labs, Vixiar Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Emerald Development Managers, startups are often financed by TEDCO, TCP Venture Capital, Robin Hood Ventures. The meaningful sponsors for the fund in investment in the same round are Robin Hood Ventures, RRE Ventures, Great Road Holdings. In the next rounds fund is usually obtained by The Toro Company, SF Capital Group, Robin Hood Ventures.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesB2B/EnterpriseCybersecurityManufacturingClimate tech
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
36
Lead investments
3
Exits
1
Rounds per year
1.20
Follow on index
0.33
Investments by industry
  • Software (12)
  • Cyber Security (12)
  • Biotechnology (9)
  • Medical (9)
  • Health Care (9)
  • Show 40 more
Investments by region
  • United States (34)
  • United Kingdom (2)
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
171M
Group Appearance index
0.81
Avg. company exit year
5
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Proscia 26 Sep 2018 Biotechnology, Software, Artificial Intelligence, Medical Early Stage Venture 8M United States, Pennsylvania, Philadelphia
Proscia 13 Mar 2024 Biotechnology, Software, Artificial Intelligence, Medical Late Stage Venture 9M United States, Pennsylvania, Philadelphia
Wisdom 03 Apr 2010 Automotive, Navigation, GPS Seed 463K Guangdong Province, Luohu District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.